Cost-Effectiveness of Dolutegravir in HIV-1 Treatment-Naive and Treatment-Experienced Patients in Canada

INTRODUCTION: The Antiretroviral Analysis by Monte Carlo Individual Simulation (ARAMIS) model was adapted to evaluate the cost-effectiveness of dolutegravir (DTG) in Canada in treatment-naive (TN) and treatment-experienced (TE) human immunodeficiency virus (HIV)-1 patients. METHODS: The ARAMIS-DTG m...

Descripción completa

Detalles Bibliográficos
Autores principales: Despiégel, Nicolas, Anger, Delphine, Martin, Monique, Monga, Neerav, Cui, Qu, Rocchi, Angela, Pulgar, Sonia, Gilchrist, Kim, Refoios Camejo, Rodrigo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575289/
https://www.ncbi.nlm.nih.gov/pubmed/26099626
http://dx.doi.org/10.1007/s40121-015-0071-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575289/
https://www.ncbi.nlm.nih.gov/pubmed/26099626
http://dx.doi.org/10.1007/s40121-015-0071-0

Ejemplares similares